Search research articles
Contact Us
Filters
Showing results (101-110 of 126) with videos related to
Page
of 13
Sort By:
Letters in Applied Microbiology
|
July 16, 2015
Exploring the expression of Pseudomonas aeruginosa genes directly from sputa of cystic fibrosis patients
C Barthe, S Nandakumar, L Derlich, et al.
The European Respiratory Journal
|
March 26, 2011
Pseudomonas aeruginosa induces vascular endothelial growth factor synthesis in airway epithelium in vitro and in vivo
C Martin, G Thévenot, S Danel, et al.
Nuclear Medicine Communications
|
July 1, 1993
Body and blood clearance and marrow radiation dose of 131I-Lym-1 in patients with B-cell malignancies
G L DeNardo, M A Mahe, S J DeNardo, et al.
American Journal of Nephrology
|
January 1, 1997
Determinants of type of initial hemodialysis vascular access
O Ifudu, L J Macey, P Homel, et al.
Clinical Chemistry and Laboratory Medicine
|
August 29, 2022
Total bilirubin assay differences may cause inconsistent treatment decisions in neonatal hyperbilirubinaemia
David H Thomas, Janet V Warner, Graham R D Jones, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 29, 1999
Phase II study of interferon-enhanced 131I-labeled high affinity CC49 monoclonal antibody therapy in patients with metastatic prostate cancer
R F Meredith, M B Khazaeli, D J Macey, et al.
Clinical Nutrition (Edinburgh, Scotland)
|
May 16, 2025
Dietary intake remains unchanged while nutritional status improves in children and adults with cystic fibrosis on Elexacaftor/Tezacaftor/Ivacaftor
R Enaud, J Languepin, M Lagarrigue, et al.
Medical Physics
|
March 1, 1993
Dosimetry of solid tumors
R F Meredith, T K Johnson, G Plott, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
July 1, 1997
Severity of AIDS and the response to EPO in uremia
O Ifudu, J J Matthew, J D Mayers, et al.
The International Journal of Biological Markers
|
January 1, 1987
Treatment of a patient with B cell lymphoma by I-131 LYM-1 monoclonal antibodies
S J DeNardo, G L DeNardo, L F O'Grady, et al.
Page
of 13
Search research articles
Search
Showing results (101-110 of 126) with videos related to
Sort By:
Page
of 13
Letters in Applied Microbiology
|
July 16, 2015
Exploring the expression of Pseudomonas aeruginosa genes directly from sputa of cystic fibrosis patients
C Barthe, S Nandakumar, L Derlich, et al.
The European Respiratory Journal
|
March 26, 2011
Pseudomonas aeruginosa induces vascular endothelial growth factor synthesis in airway epithelium in vitro and in vivo
C Martin, G Thévenot, S Danel, et al.
Nuclear Medicine Communications
|
July 1, 1993
Body and blood clearance and marrow radiation dose of 131I-Lym-1 in patients with B-cell malignancies
G L DeNardo, M A Mahe, S J DeNardo, et al.
American Journal of Nephrology
|
January 1, 1997
Determinants of type of initial hemodialysis vascular access
O Ifudu, L J Macey, P Homel, et al.
Clinical Chemistry and Laboratory Medicine
|
August 29, 2022
Total bilirubin assay differences may cause inconsistent treatment decisions in neonatal hyperbilirubinaemia
David H Thomas, Janet V Warner, Graham R D Jones, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 29, 1999
Phase II study of interferon-enhanced 131I-labeled high affinity CC49 monoclonal antibody therapy in patients with metastatic prostate cancer
R F Meredith, M B Khazaeli, D J Macey, et al.
Clinical Nutrition (Edinburgh, Scotland)
|
May 16, 2025
Dietary intake remains unchanged while nutritional status improves in children and adults with cystic fibrosis on Elexacaftor/Tezacaftor/Ivacaftor
R Enaud, J Languepin, M Lagarrigue, et al.
Medical Physics
|
March 1, 1993
Dosimetry of solid tumors
R F Meredith, T K Johnson, G Plott, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
July 1, 1997
Severity of AIDS and the response to EPO in uremia
O Ifudu, J J Matthew, J D Mayers, et al.
The International Journal of Biological Markers
|
January 1, 1987
Treatment of a patient with B cell lymphoma by I-131 LYM-1 monoclonal antibodies
S J DeNardo, G L DeNardo, L F O'Grady, et al.
Page
of 13